Imatinib "Accord"

{
  "EntityId": "8247",
  "LastUpdated": "2026-07-17T00:34:23.005062\u002B02:00",
  "LastRevisedDate": {
    "Header": "Revisionsdato",
    "Value": "\u003Cdiv id=\u0022revisionsdato\u0022\u003E\u003Cp\u003E\u003Cspan class=\u0022dato\u0022\u003EMandag den 29. juni 2026\u003C/span\u003E. Priserne er dog g\u00E6ldende pr.\u003Cspan class=\u0022dato\u0022\u003Emandag den 6. juli 2026.\u003C/span\u003E\u003Cdiv class=\u0022smalltext\u0022\u003EDer kan forekomme forskelle mellem pr\u00E6paratbeskrivelsen og oplysningerne i produktresumeet og/eller indl\u00E6gssedlen. Det skyldes, at min.medicin.dk kan have suppleret L\u00E6gemiddelstyrelsens og producentens pr\u00E6paratinformationer med andre kilder. Min.medicin.dk har det fulde ansvar for pr\u00E6paratbeskrivelserne.\u003C/div\u003E\u003C/p\u003E\u003C/div\u003E"
  },
  "MedicineName": {
    "Header": "Pr\u00E6paratnavn",
    "Value": "Imatinib \u0022Accord\u0022"
  },
  "TradeNames": {
    "Header": "Handelsnavne",
    "Value": []
  },
  "Slug": "imatinib-accord",
  "CompanyName": {
    "Header": "Firmanavn",
    "Value": "Accord"
  },
  "Usage": {
    "Header": "Bruges mod",
    "Value": "\u003Cdiv id=\u0022anvendelse\u0022\u003E\u003Cp\u003EImatinib \u0022Accord\u0022 er et middel til immunterapi (enzymh\u00E6mmer).\u003C/p\u003E\u003Cp\u003EImatinib \u0022Accord\u0022 anvendes til behandling af\u003C/p\u003E\u003Cul\u003E\u003Cli\u003Evisse former for leuk\u00E6mi (kr\u00E6ft i blodet) \u003C/li\u003E\u003Cli\u003Ekr\u00E6ft i bindev\u00E6vet i mave-tarmsystemet (GIST) \u003C/li\u003E\u003Cli\u003Ekr\u00E6ft i v\u00E6vet under huden (DFSP). \u003C/li\u003E\u003C/ul\u003E\u003Cp\u003EM\u00E5 kun udleveres fra sygehus.\u003C/p\u003E\u003C/div\u003E"
  },
  "Dosage": {
    "Header": "Dosering",
    "Value": "\u003Cdiv id=\u0022doseringsforslag\u0022\u003E\u003Cp\u003EFindes som tabletter.\u003C/p\u003E\u003Cp\u003EBehandlingen er individuel og afpasses dels efter virkningen, dels efter graden og omfanget af bivirkninger. \u003C/p\u003E\u003Cp\u003E\u003Cb\u003EBem\u00E6rk:\u003C/b\u003E\u003C/p\u003E\u003Cp\u003EDelek\u00E6rvens form\u00E5l er ikke at kunne dele tabletten. \u003C/p\u003E\u003Cp\u003EDosis skal neds\u00E6ttes ved d\u00E5rligt fungerende nyrer (GFR 0-60 ml/min)\u003C/p\u003E\u003Cbr/\u003E\u003C/div\u003E"
  },
  "HowToUse": {
    "Header": "S\u00E5dan tager du medicinen",
    "Value": {
      "KnuseDeleInformation": {
        "Header": "H\u00E5ndtering",
        "Value": "\u003Cdiv id=\u0022KnuseDeleInformation\u0022\u003E\u003Cp\u003E\u003Cdiv\u003E\u003Ch4\u003E\u003Cspan data-drugid=\u002228105121112\u0022\u003E\u003Cb\u003EFilmovertrukne tabletter 100 mg og 400 mg\u003C/b\u003E\u003C/span\u003E\u003Cbr/\u003E\u003C/h4\u003E\u003Cbr/\u003E\u003Cb\u003EMad og drikke\u003C/b\u003E\u003Cdiv\u003ETages med et glas vand\u003Cbr/\u003EIndtagelse sammen med mad neds\u00E6tter risikoen for bivirkninger i mave-tarm-kanalen\u003C/div\u003E\u003Cbr/\u003E\u003Cb\u003EKnusning/\u00E5bning\u003C/b\u003E\u003Cdiv\u003EM\u00E5 ikke knuses\u003C/div\u003E\u003Cbr/\u003E\u003Cb\u003EAdministration\u003C/b\u003E\u003Cdiv\u003ETablet kan opsl\u00E6mmes i vand eller \u00E6blejuice\u003C/div\u003E\u003Cbr/\u003E\u003Cb\u003EAndet\u003C/b\u003E\u003Cdiv\u003EBem\u00E6rk - personalerisiko\u003Cp\u003E\u003Cb\u003EBem\u00E6rk - personalerisiko:\u003C/b\u003E Ved h\u00E5ndtering af dette l\u00E6gemiddel b\u00F8r udvises forsigtighed.\u003C/p\u003E\u003C/div\u003E\u003C/div\u003E\u003C/p\u003E\u003C/div\u003E"
      },
      "Termination": {
        "Header": "Stop af behandling",
        "Value": null
      },
      "MissedDose": {
        "Header": "Glemt medicin",
        "Value": null
      }
    }
  },
  "Precautions": {
    "Header": "Det skal du vide, n\u00E5r du tager medicinen",
    "Value": {
      "Contraindications": {
        "Header": "Hvorn\u00E5r m\u00E5 du ikke tage medicinen?",
        "Value": null
      },
      "RulesOfCaution": {
        "Header": "S\u00E6rlige advarsler",
        "Value": "\u003Cdiv id=\u0022saerligeadvarsler\u0022\u003E\u003Cul\u003E\u003Cli\u003EDa midlet kan for\u00E5rsage alvorlig v\u00E6skeophobning i kroppen, skal v\u00E6gtkontrol foretages j\u00E6vnligt. \u003C/li\u003E\u003Cli\u003EDer er meget sparsomme erfaringer med behandling af b\u00F8rn og unge under 18 \u00E5r og ingen erfaring med behandling af b\u00F8rn under 1 \u00E5r. Der er set v\u00E6ksth\u00E6mning hos b\u00F8rn i behandling med imatinib, og b\u00F8rns v\u00E6kst b\u00F8r derfor f\u00F8lges n\u00F8je under behandlingen. \u003C/li\u003E\u003Cli\u003EOpblussen af leverbet\u00E6ndelse kan forekomme. \u003C/li\u003E\u003Cli\u003EDa behandlingen kan \u00F8ge hudens f\u00F8lsomhed over for sollys (ogs\u00E5 solarielys), skal direkte sollys s\u00E5 vidt muligt undg\u00E5s, og huden b\u00F8r beskyttes med solcreme med h\u00F8j faktor. \u003C/li\u003E\u003C/ul\u003E\u003C/div\u003E"
      },
      "Interactions": {
        "Header": "Brug af anden medicin",
        "Value": "\u003Cdiv id=\u0022brugafandenmedicin\u0022\u003E\u003Cp\u003EDet er vigtigt at informere l\u00E6gen om alle de l\u00E6gemidler, du tager.\u003C/p\u003E\u003Cul\u003E\u003Cli\u003EAntibiotika (clarithromycin, erythromycin), svampemidler (itraconazol, ketoconazol, voriconazol), fluoxetin (middel mod depression) samt proteaseh\u00E6mmere (midler mod HIV) kan \u00F8ge virkningen af Imatinib \u0022Accord\u0022. \u003C/li\u003E\u003Cli\u003EEpilepsimidler (carbamazepin, phenobarbital og phenytoin), binyrebarkhormon (prednisolon), naturl\u00E6gemidler med perikon samt tuberkulosemidler (rifabutin og rifampicin) kan neds\u00E6tte virkningen af Imatinib \u0022Accord\u0022. \u003C/li\u003E\u003Cli\u003EImatinib \u0022Accord\u0022 kan \u00F8ge virkningen af simvastatin (kolesterolneds\u00E6ttende). \u003C/li\u003E\u003Cli\u003EImatinib \u0022Accord\u0022 kan p\u00E5virke virkningen af blodfortyndende midler, fx warfarin. \u003C/li\u003E\u003Cli\u003ESamtidig behandling med paracetamol (middel mod smerter) kan give alvorligt leversvigt.\u003C/li\u003E\u003Cli\u003ESamtidig behandling med meto kan forsinke udskillelsen af methotrexat, is\u00E6r n\u00E5r methotrexat anvendes i h\u00F8je doser (\u0026gt; 500 mg/m\u00B2). Forsigtighed anbefales ved samtidig brug. \u003C/li\u003E\u003C/ul\u003E\u003C/div\u003E"
      },
      "Pregnancy": {
        "Header": "Graviditet og fertilitet",
        "Value": "\u003Cdiv id=\u0022graviditet\u0022\u003EM\u00E5 kun anvendes under visse foruds\u00E6tninger.\u003Cp\u003EDer er \u00F8get risiko for misdannelser ved brug af midlet til gravide. B\u00F8r kun anvendes i s\u00E6rlige tilf\u00E6lde efter aftale med speciall\u00E6gen.\u003C/p\u003E\u003Cp\u003E\u003C/p\u003E\u003Cb\u003EFertile kvinder og m\u00E6nd\u003C/b\u003E\u003Cbr/\u003E\u003Cp\u003EKvinder i den f\u00F8dedygtige alder b\u00F8r anvende sikker pr\u00E6vention under behandlingen og indtil 15 dage efter oph\u00F8r med behandlingen.\u003C/p\u003E\u003C/div\u003E"
      },
      "Lactation": {
        "Header": "Amning",
        "Value": "\u003Cdiv id=\u0022amning\u0022\u003EM\u00E5 ikke anvendes. Denne tekst afviger fra firmaets godkendte produktinformation (produktresum\u00E9).\u003C/div\u003E"
      },
      "Alchohol": {
        "Header": "Alkohol",
        "Value": "\u003Cdiv id=\u0022alkohol\u0022\u003E\u003Cp\u003E\u003Cp\u003EAlkohol og Imatinib \u0022Accord\u0022 p\u00E5virker ikke hinanden.\u003C/p\u003E\u003Cp\u003EF\u00F8lg dog altid Sundhedsstyrelsens anbefalinger om genstandsgr\u00E6nser.\u003C/p\u003E\u003C/p\u003E\u003C/div\u003E"
      },
      "BloodDonor": {
        "Header": "Bloddonor",
        "Value": "\u003Cdiv id=\u0022bloddonor\u0022\u003EM\u00E5 ikke tappes. Donor skal sandsynligvis udmeldes af bloddonorkorpset.\u003C/div\u003E"
      },
      "Doping": {
        "Header": "Doping",
        "Value": null
      },
      "Traffic": {
        "Header": "Trafik",
        "Value": null
      },
      "SchengenCertificate": {
        "Header": "Schengenattest (pillepas)",
        "Value": null
      },
      "ShelfLifeAndStorage": {
        "Header": "Holdbarhed og opbevaring",
        "Value": null
      }
    }
  },
  "SideEffects": {
    "Header": "Bivirkninger",
    "Value": {
      "VeryCommon": {
        "Header": "Meget almindelige",
        "Comment": "Flere end 10 ud af 100 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Blodmangel",
              "\u00D8get risiko for infektioner pga. mangel p\u00E5 hvide blodlegemer",
              "\u00D8get tendens til bl\u00F8dning pga. fald i antallet af blodplader",
              "Mavesmerter",
              "H\u00E6velse omkring \u00F8jnene",
              "Knoglesmerter",
              "Ledsmerter",
              "Muskelkramper",
              "Bet\u00E6ndelse i huden",
              "H\u00E6velser pga. v\u00E6skeophobning i kroppen"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "Diarr\u00E9",
              "Ford\u00F8jelsesbesv\u00E6r",
              "Kvalme",
              "Opkastning",
              "Tr\u00E6thed",
              "V\u00E6gt\u00F8gning",
              "Muskelsmerter",
              "Hovedpine",
              "Hududsl\u00E6t",
              "V\u00E6skeophobning i kroppen"
            ]
          }
        }
      },
      "Common": {
        "Header": "Almindelige",
        "Comment": "H\u00F8jst 10 ud af 100 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Blodmangel og \u00F8get risiko for infektioner pga. mangel p\u00E5 hvide blodlegemer",
              "Tendens til bl\u00F8dninger",
              "Synsforstyrrelser",
              "\u00D8jenbet\u00E6ndelse",
              "V\u00E6skeophobning i ansigtet",
              "Leverp\u00E5virkning",
              "Ledstivhed",
              "Svimmelhed",
              "\u00C6ndring i hudens f\u00F8lesans",
              "\u00C5nden\u00F8d",
              "H\u00E5rtab",
              "Overf\u00F8lsomhed over for sollys"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "H\u00E6vede \u00F8jenl\u00E5g",
              "\u00D8get t\u00E5reproduktion",
              "Luft fra tarmen",
              "Mundt\u00F8rhed",
              "Smagsforstyrrelser",
              "Sure opst\u00F8d",
              "Feber",
              "Kulderystelser",
              "V\u00E6gttab",
              "Nedsat appetit",
              "S\u00F8vnl\u00F8shed",
              "Hoste",
              "N\u00E6seblod",
              "Hudkl\u00F8e",
              "T\u00F8r hud",
              "\u00D8get svedtendens",
              "Pludselig r\u00F8dme og varmef\u00F8lelse"
            ]
          }
        }
      },
      "Uncommon": {
        "Header": "Ikke almindelige",
        "Comment": "H\u00F8jst 1 ud af 100 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Hjertesvigt",
              "H\u00F8retab",
              "Tinnitus",
              "Bl\u00F8dning i mave-tarm-kanalen",
              "Infektioner",
              "V\u00E6skemangel",
              "Ledbet\u00E6ndelse",
              "Nedbrydning af knoglev\u00E6v",
              "Nervebet\u00E6ndelse fx p\u00E5 arme og ben",
              "Rysten",
              "Angst",
              "Depression",
              "Akut nyresvigt",
              "Blod i urinen",
              "V\u00E6ske i lungerne",
              "Alvorlig hudreaktion",
              "Sm\u00E5bl\u00F8dninger i hud og slimhinder",
              "Besvimelsesanfald",
              "Hjernebl\u00F8dning"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": [
              "Nedsat sexlyst",
              "Forandringer af neglene",
              "\u00C6ndret farve i huden"
            ]
          }
        }
      },
      "Rare": {
        "Header": "Sj\u00E6ldne",
        "Comment": "H\u00F8jst 1 ud af 1.000 personer f\u00E5r bivirkningen.",
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Blodprop i hjertet",
              "Hjertestop",
              "Bet\u00E6ndelse i synsnerven",
              "Allergisk h\u00E6velse i ansigtet samt mundhulen og strubehovedet",
              "Kramper",
              "Arv\u00E6v i lungerne",
              "Hududsl\u00E6t med bl\u00E6redannelse",
              "Blodpropper og bl\u00F8dning i de sm\u00E5 kar"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": []
          }
        }
      },
      "VeryRare": {
        "Header": "Meget sj\u00E6ldne",
        "Comment": null,
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": []
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": []
          }
        }
      },
      "FrequencyNotKnown": {
        "Header": "Ikke kendt",
        "Comment": null,
        "Value": {
          "SeriousAdverseReactions": {
            "Header": "Potentielt alvorlige bivirkninger",
            "Value": [
              "Bet\u00E6ndelse i hjertets hinder",
              "V\u00E6skeophobning i hjertes\u00E6kken",
              "V\u00E6ksth\u00E6mning",
              "Bl\u00F8dning i \u00F8jet",
              "Bet\u00E6ndelse i nedre del af tyktarmen",
              "Forstoppelse",
              "Hul p\u00E5 tarmen",
              "Tarmslyng",
              "Allergiske reaktioner",
              "V\u00E6skeophobning i hjernen",
              "Tendens til bl\u00F8dning fra svulsten",
              "Vedvarende nyresvigt",
              "Lungesygdom",
              "Alvorlig hudreaktion hvor huden g\u00E5r til grunde",
              "Alvorligt udsl\u00E6t og f\u00F8leforstyrrelser p\u00E5 h\u00E6nder og f\u00F8dder",
              "Blodprop"
            ]
          },
          "NonSeriousAdverseReactions": {
            "Header": "Oftest ikke alvorlige bivirkninger",
            "Value": []
          }
        }
      }
    },
    "AdditionalSideEffectsText": "\u003Cp\u003EHvis organismen ikke er i stand til at skille sig af med alle de celler, som l\u00E6gemidlet har \u00F8delagt, kan der opst\u00E5 s\u00E5kaldt tumorlyse, som kan f\u00F8re til et unormalt h\u00F8jt niveau af affaldsstoffer i blodet og eventuelt nyresvigt. Hvis der opst\u00E5r smerter i siden, eller hvis der er blod i urinen, kan det v\u00E6re et tegn p\u00E5 tumorlyse, og i dette tilf\u00E6lde skal man s\u00F8ge l\u00E6ge.\u003C/p\u003E"
  },
  "ActiveSubstances": {
    "Header": "Virksomme stoffer",
    "Value": [
      {
        "Name": "Imatinib"
      }
    ]
  },
  "Products": {
    "Header": "Priser, pakninger og tilskud",
    "Value": [
      {
        "ProductNumber": "425282",
        "DisplayName": "Imatinib \u0022Accord\u0022 100 mg / 60 stk. (blister)",
        "Packaging": "60 stk. (blister)",
        "Price": 8607.65,
        "PricePerUnit": 143.46,
        "TradeName": "Imatinib \u0022Accord\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "100 mg",
        "Dispensing": "Kun til sygehuse",
        "Reimbursement": "Intet tilskud",
        "ExpirationDate": null,
        "IsVariablePrice": false,
        "Substitutes": [
          {
            "ProductNumber": "382112",
            "Slug": "imatinib-stada",
            "DisplayName": "Imatinib \u0022Stada\u0022 100 mg / 60 stk.",
            "Price": 8400.45,
            "PricePerUnit": 140.01,
            "SubstitutionPriceGroup": "A",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "463049",
            "Slug": "imatinib-accord",
            "DisplayName": "Imatinib \u0022Accord\u0022 100 mg / 60 stk. (unit-dose)",
            "Price": 8432.85,
            "PricePerUnit": 140.55,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "104833",
            "Slug": "bimatix",
            "DisplayName": "Bimatix 100 mg / 60 stk. (unit-dose)",
            "Price": 8439.3,
            "PricePerUnit": 140.66,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "053841",
            "Slug": "imatinib-sandoz",
            "DisplayName": "Imatinib \u0022Sandoz\u0022 100 mg / 60 stk. (blister)",
            "Price": 10606.05,
            "PricePerUnit": 176.77,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "409601",
            "Slug": "imatinib-zentiva",
            "DisplayName": "Imatinib \u0022Zentiva\u0022 100 mg / 60 stk. (blister)",
            "Price": 10950.3,
            "PricePerUnit": 182.5,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          }
        ]
      },
      {
        "ProductNumber": "463049",
        "DisplayName": "Imatinib \u0022Accord\u0022 100 mg / 60 stk. (unit-dose)",
        "Packaging": "60 stk. (unit-dose)",
        "Price": 8432.85,
        "PricePerUnit": 140.55,
        "TradeName": "Imatinib \u0022Accord\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "100 mg",
        "Dispensing": "Kun til sygehuse",
        "Reimbursement": "Intet tilskud",
        "ExpirationDate": null,
        "IsVariablePrice": false,
        "Substitutes": [
          {
            "ProductNumber": "382112",
            "Slug": "imatinib-stada",
            "DisplayName": "Imatinib \u0022Stada\u0022 100 mg / 60 stk.",
            "Price": 8400.45,
            "PricePerUnit": 140.01,
            "SubstitutionPriceGroup": "A",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "104833",
            "Slug": "bimatix",
            "DisplayName": "Bimatix 100 mg / 60 stk. (unit-dose)",
            "Price": 8439.3,
            "PricePerUnit": 140.66,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "425282",
            "Slug": "imatinib-accord",
            "DisplayName": "Imatinib \u0022Accord\u0022 100 mg / 60 stk. (blister)",
            "Price": 8607.65,
            "PricePerUnit": 143.46,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "053841",
            "Slug": "imatinib-sandoz",
            "DisplayName": "Imatinib \u0022Sandoz\u0022 100 mg / 60 stk. (blister)",
            "Price": 10606.05,
            "PricePerUnit": 176.77,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "409601",
            "Slug": "imatinib-zentiva",
            "DisplayName": "Imatinib \u0022Zentiva\u0022 100 mg / 60 stk. (blister)",
            "Price": 10950.3,
            "PricePerUnit": 182.5,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          }
        ]
      },
      {
        "ProductNumber": "104423",
        "DisplayName": "Imatinib \u0022Accord\u0022 400 mg / 30 stk. (blister)",
        "Packaging": "30 stk. (blister)",
        "Price": 16656.1,
        "PricePerUnit": 555.2,
        "TradeName": "Imatinib \u0022Accord\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "400 mg",
        "Dispensing": "Kun til sygehuse",
        "Reimbursement": "Intet tilskud",
        "ExpirationDate": null,
        "IsVariablePrice": false,
        "Substitutes": [
          {
            "ProductNumber": "420762",
            "Slug": "bimatix",
            "DisplayName": "Bimatix 400 mg / 30 stk. (unit-dose)",
            "Price": 16649.6,
            "PricePerUnit": 554.99,
            "SubstitutionPriceGroup": "A",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "079148",
            "Slug": "imatinib-stada",
            "DisplayName": "Imatinib \u0022Stada\u0022 400 mg / 30 stk.",
            "Price": 16662.55,
            "PricePerUnit": 555.42,
            "SubstitutionPriceGroup": "B",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "560682",
            "Slug": "imatinib-accord",
            "DisplayName": "Imatinib \u0022Accord\u0022 400 mg / 30 stk. (blister)",
            "Price": 18799.3,
            "PricePerUnit": 626.64,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "051492",
            "Slug": "imatinib-sandoz",
            "DisplayName": "Imatinib \u0022Sandoz\u0022 400 mg / 30 stk. (blister)",
            "Price": 21190.25,
            "PricePerUnit": 706.34,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "543641",
            "Slug": "imatinib-zentiva",
            "DisplayName": "Imatinib \u0022Zentiva\u0022 400 mg / 30 stk. (blister)",
            "Price": 21599.1,
            "PricePerUnit": 719.97,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          }
        ]
      },
      {
        "ProductNumber": "560682",
        "DisplayName": "Imatinib \u0022Accord\u0022 400 mg / 30 stk. (blister)",
        "Packaging": "30 stk. (blister)",
        "Price": 18799.3,
        "PricePerUnit": 626.64,
        "TradeName": "Imatinib \u0022Accord\u0022",
        "PharmaceuticalForm": "Filmovertrukne tabletter",
        "DrugStrength": "400 mg",
        "Dispensing": "Kun til sygehuse",
        "Reimbursement": "Intet tilskud",
        "ExpirationDate": null,
        "IsVariablePrice": false,
        "Substitutes": [
          {
            "ProductNumber": "420762",
            "Slug": "bimatix",
            "DisplayName": "Bimatix 400 mg / 30 stk. (unit-dose)",
            "Price": 16649.6,
            "PricePerUnit": 554.99,
            "SubstitutionPriceGroup": "A",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "104423",
            "Slug": "imatinib-accord",
            "DisplayName": "Imatinib \u0022Accord\u0022 400 mg / 30 stk. (blister)",
            "Price": 16656.1,
            "PricePerUnit": 555.2,
            "SubstitutionPriceGroup": "B",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "079148",
            "Slug": "imatinib-stada",
            "DisplayName": "Imatinib \u0022Stada\u0022 400 mg / 30 stk.",
            "Price": 16662.55,
            "PricePerUnit": 555.42,
            "SubstitutionPriceGroup": "B",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "051492",
            "Slug": "imatinib-sandoz",
            "DisplayName": "Imatinib \u0022Sandoz\u0022 400 mg / 30 stk. (blister)",
            "Price": 21190.25,
            "PricePerUnit": 706.34,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          },
          {
            "ProductNumber": "543641",
            "Slug": "imatinib-zentiva",
            "DisplayName": "Imatinib \u0022Zentiva\u0022 400 mg / 30 stk. (blister)",
            "Price": 21599.1,
            "PricePerUnit": 719.97,
            "SubstitutionPriceGroup": "C",
            "ExpirationDate": null,
            "IsVariablePrice": false
          }
        ]
      }
    ]
  },
  "Excipients": {
    "Header": "Hj\u00E6lpestoffer",
    "Value": [
      "\u003Cdiv id=\u0022hjaelpestoffer\u0022\u003E\u003Cp\u003E\u003Cb\u003EFarve:\u003C/b\u003E\u003C/p\u003E\u003Cspan class=\u0022navn\u0022\u003EJernoxider og jernhydroxider (E172)\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cp\u003E\u003Cb\u003EAndre:\u003C/b\u003E\u003C/p\u003E\u003Cspan class=\u0022navn\u0022\u003EPolyethylenglycol\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003ECrospovidon\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EHypromellose\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EKolloid silica\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EMacrogoler\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EMagnesiumstearat\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003Cbr/\u003E\u003Cspan class=\u0022navn\u0022\u003EMikrokrystallinsk cellulose\u003C/span\u003E : \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 100 mg\u003C/span\u003E, \u003Cspan class=\u0022dispenseringsformogstyrke\u0022\u003Efilmovertrukne tabletter 400 mg\u003C/span\u003E\u003C/div\u003E"
    ]
  },
  "PharmacologicalEffect": {
    "Header": "S\u00E5dan virker medicinen",
    "Value": "\u003Cdiv id=\u0022virkning\u0022\u003E\u003Cul\u003E\u003Cli\u003EVirker ved at h\u00E6mme et enzym, \u003Ci\u003Etyrosinkinase\u003C/i\u003E, som \u00F8ger v\u00E6ksten af kr\u00E6ftcellerne. \u003C/li\u003E\u003Cli\u003EHalveringstiden i blodet (T\u00BD) er ca. 40 timer.\u003C/li\u003E\u003C/ul\u003E\u003C/div\u003E"
  },
  "Reimbursement": {
    "Header": "Tilskud",
    "Value": null
  }
}